EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of COVID-19 rapid antigen test against polymerase chain reaction test in immunocompromised patients

Ali Sabateen, Dana Sadaqa iD, Taleen Nino, Ghayd Zaghal, George Qumsieh, Reena Fakhori, Hammam Rjoub, Tahreer Taha, Rami Zghari, Sari Abu Hanieh, Duaa Al-Basha, Marwan Qabaja und 2 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0306396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ali Sabateen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Augusta Victoria Hospital, East Jerusalem, Palestine. Hauptthemen laut MEDLINE: Immunocompromised Host, COVID-19, SARS-CoV-2, Sensitivity and Specificity. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On the 11 th of March 2020, the world faced a new global pandemic, COVID-19 which is a disease caused by the novel coronavirus, it had multiple devastating outcomes on multiple sectors along with significant rates of mortality. These challenges encouraged the development of multiple testing methods, as well as anti-viral medications such as Molnupiravir, as well as evaluating the efficacy of available medications against it, like; Azithromycin, Ritonavir and Hydroxychloroquine. Vaccination against COVID-19 forged into a significant challenge, few months ensuing the first case of SARS-CoV-2, which was diagnosed in December 2019, in Wuhan-China, thus, multiple vaccines were approved for use around the world to combat this pandemic. Our study includes a sample of 556 oncology patients at Augusta Victoria Hospital in Jerusalem, all patients were tested using Panbio rapid antigen test and Allplex PCR Assay. The main objective was to study the sensitivity and specificity of Rapid antigen test, which contributes to a faster isolation call and management of infected patients, thus decreasing the risk on spread to other patients and health care. Patients were categorized based on two factors: Ct range and age group and studying their possible effect on false-negative results. Patients with Ct value less than 20, had the highest detection rate which is consistent with other studies in the literature. The sensitivity and specificity of Panbio Rapid Antigen testing were of 69.9% and 100%, respectively. A correlation between age group and false negative results could not be made, but a correlation between Ct value and false negative result was noticed, Ct value was directly related to false negative results. P-value of 0.007 indicated that results were statistically significant where PCR test is considered more sensitive compared to rapid antigen test.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostCOVID-19SARS-CoV-2Sensitivity and SpecificityHumansMiddle AgedFemaleMaleAdultAgedYoung AdultAdolescentPolymerase Chain ReactionCOVID-19 Serological TestingAged, 80 and overAntigens, ViralFalse Negative Reactions

Substanzen

Antigens, Viral

Autor:innen und Institutionen

  • Infectious Diseases Unit, Augusta Victoria Hospital, East Jerusalem, Palestine.
  • Molecular Laboratory, Augusta Victoria Hospital, East Jerusalem, Palestine.
  • Pharmacy Department, Modern University College (MUC), Ramallah, Palestine.
  • Pathology Laboratory, Augusta Victoria Hospital, East Jerusalem, Palestine.
  • Internal Medicine Department, Hadassah University Hospital, Jerusalem, Israel.

ORCID-Profile: Dana Sadaqa

Zitieren

APA

Sabateen, A., Sadaqa, D., Nino, T., Zaghal, G., Qumsieh, G., Fakhori, R., Rjoub, H., Taha, T., Zghari, R., Abu Hanieh, S., Al-Basha, D., Qabaja, M., Alsaid, H., & Hindiyeh, M. Y. (2024). Evaluation of COVID-19 rapid antigen test against polymerase chain reaction test in immunocompromised patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0306396

Vancouver

Sabateen A, Sadaqa D, Nino T, Zaghal G, Qumsieh G, Fakhori R, et al. Evaluation of COVID-19 rapid antigen test against polymerase chain reaction test in immunocompromised patients. PLOS ONE. 2024. doi:10.1371/journal.pone.0306396

BibTeX
@article{Sabateen2024,
  author = {Sabateen, Ali and Sadaqa, Dana and Nino, Taleen and Zaghal, Ghayd and Qumsieh, George and Fakhori, Reena and Rjoub, Hammam and Taha, Tahreer and Zghari, Rami and Abu Hanieh, Sari and Al-Basha, Duaa and Qabaja, Marwan and Alsaid, Hamza and Hindiyeh, Musa Y},
  title = {Evaluation of COVID-19 rapid antigen test against polymerase chain reaction test in immunocompromised patients},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0306396}
}
Kostenlos starten →